XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flow from Operating Activities:            
Net Income Attributable to the Company       $ 6,237 $ 28,008  
Adjustments to Reconcile Net Income Attributable to the Company to Net Cash Provided by Operating Activities:            
Depreciation and Amortization       20,401 15,428  
Amortization of Intangible Liabilities to Income Property Revenue $ 507   $ (86) 1,485 (820)  
Amortization of Deferred Financing Costs to Interest Expense 178   120 515 444  
Amortization of Discount on Convertible Debt 40   322 149 951  
Gain on Disposition of Assets       (3,921) (28,106)  
Gain on Disposition of Commercial Loans and Investments       (807)    
Loss on Extinguishment of Debt         641  
Impairment Charges 0     0 16,527  
Accretion of Commercial Loans and Investments Origination Fees       (150) (1)  
Non-Cash Imputed Interest       (119) (330)  
Deferred Income Taxes       (544) (3,736)  
Unrealized (Gain) Loss on Investment Securities       8,102 (6,894)  
Non-Cash Compensation       2,423 2,434  
Decrease (Increase) in Assets:            
Refundable Income Taxes       (5) (830)  
Assets Held for Sale         (1)  
Land and Development Costs       7 381  
Mitigation Credits and Mitigation Credit Rights       1,876 (16,007)  
Other Assets       (7,895) (945)  
Increase in Liabilities:            
Accounts Payable       460 1,084  
Accrued and Other Liabilities       4,531 3,800  
Deferred Revenue       1,335 337  
Net Cash Provided By Operating Activities       34,080 12,365  
Cash Flow from Investing Activities:            
Acquisition of Real Estate and Intangible Lease Assets and Liabilities       (112,843) (115,780)  
Acquisition of Commercial Loans and Investments       (50,130) (364)  
Restricted Cash Balance Received in Acquisition of Interest in Joint Venture         595  
Cash Contribution to Joint Ventures         (639)  
Proceeds from Disposition of Property, Plant, and Equipment, Net, and Assets Held for Sale       40,777 108,449  
Principal Payments Received on Commercial Loans and Investments       44,079    
Acquisition of Investment Securities       (2,253)    
Net Cash Used In Investing Activities       (80,370) (7,739)  
Cash Flow From Financing Activities:            
Proceeds from Long-Term Debt       218,500 156,500  
Payments on Long-Term Debt       (147,000) (171,308)  
Cash Paid for Loan Fees       (2,610) (907)  
Cash Paid for Exercise of Stock Options and Common Stock Issuance       (177) (146)  
Proceeds from Issuance of Preferred Stock, Net of Underwriting Discount and Expenses         72,439  
Cash Used to Purchase Common Stock       (2,792)    
Cash Paid for Vesting of Restricted Stock       (845) (452)  
Proceeds from (Cash Paid for) Issuance of Common Stock, Net       20,567 (197)  
Dividends Paid - Preferred Stock       (3,586) (1,129)  
Dividends Paid - Common Stock       (20,292) (17,700)  
Net Cash Provided By Financing Activities       61,765 37,100  
Net Increase in Cash, Cash Equivalents and Restricted Cash       15,475 41,726  
Cash, Cash Equivalents and Restricted Cash, Beginning of Period   $ 75,551   31,349 33,825 $ 33,825
Cash, Cash Equivalents and Restricted Cash, End of Period 46,824 31,349 75,551 46,824 75,551 31,349
Reconciliation of Cash to the Consolidated Balance Sheets:            
Cash and Cash Equivalents 9,532 8,615 7,005 9,532 7,005 8,615
Restricted Cash 37,292 22,734 68,546 37,292 68,546 22,734
Total Cash $ 46,824 $ 31,349 $ 75,551 $ 46,824 $ 75,551 $ 31,349